Biochip Scanner Market: Size, Dynamics, Regional Insights, and Market Segment Analysis

Biochip Scanner Market was valued at USD 12.79 Bn. in 2023, and it is expected to reach USD 27.36 Bn. by 2030, exhibiting a CAGR of 11.47% during the forecast period (2024-2030)
Biochip Scanner Market Overview:
Advances in the areas of proteomics, genomics, and pharmaceuticals are empowering scientists with innovative methods for unraveling complex biochemical processes, with the larger goal of understanding and treating human diseases. With the growth in technology and the emergence of nanotechnology, biochips scanner provides easy and reliable solutions to mankind in tackling health issues. The emergence of biochip technology has revolutionized and added a new dimension to diagnostics technology and there has been great enthusiasm amongst the medical fraternity about its implications on human health.To know about the Research Methodology :- Request Free Sample Report
Biochip Scanner Market Dynamics
Semiconductor Industry Has Been Steadily Perfecting the Science of Micro-Miniaturization for Biochip Scanner Production

The merging of healthcare and semiconductor fields led to the development of Biochip which enabled Biotechnologists to begin packing their traditionally bulky sensing tools into smaller and slighter spaces. The biochip is continuing to evolve as a collection of assays that provide a technology platform. As humans prepare for the exploration of the solar system, there is a growing requirement for miniaturized medical and environmental diagnostic devices for use on spacecraft, especially during long-duration space missions where size and power requirements are critical.

Biochip scanner is becoming a hotspot segment for emerging market Key Players

Key Players are focusing to provide life-changing technologies and services to help people live healthier. With the cutting-edge technologies that bring population and data together to unlock their full potential, key players are breaking down barriers to assist people and take control of their health. The adoption of personalized medicines and next-generation sequencing (NGS), and drug development are boosting the demand for biochips. Innovation in the Lab-on-a-chip offerings along with the biomedical for microfluidic-based devices is expected to drive the production of the biochip in the forecast year.

Increasing applications of biochips in proteomics, genomics, and drug discovery, and high expenditure on research and development, are some of the prominent factors, which are expected to boost the biochip scanner market revenue growth. Additionally, biochips are growing in popularity for personalized treatment and are becoming more often used for allergy detection.

A rise in the use of biochips in animal medical testing is expected to contribute to revenue growth and the occurrence of life-threatening disorders. The increasing use of biochips for cancer therapy, drug discovery, and life science research is boosting the demand for the biochip scanner market. According to the American Cancer Society, 21.7 million new instances of cancer are expected to be diagnosed by 2030.

Technical Developments in The Biochip Scanner Industry

New developments in the healthcare segment have impacted strongly on a single aspect in the manufacturing of devices and products of the biochip scanner, which are currently available on the market. Biochips are now more valuable in diagnostics, research, medication development, and toxicological studies thanks to advances in nanotechnology that have increased their capacity and decreased their size.

The biochip industry is growing rapidly because of the technology development in the healthcare sector. Biochips offer many benefits over traditional data collection and analysis methods. Many researchers and laboratories are working together to create innovative biochips that help to analyse and treatment on cancer.

A new biochip, which helps to reduce the cost of manufacturing in vitro skin has been developed in 2022. Researchers from the Universidad Carlos, the Universidad Politécnica de Madrid (UPM), and other entities have designed a new biochip, a device that streamlines the process of manufacturing in vitro skin in the laboratory and other complex multi-layer tissues.

The high cost of production of the biochip scanner creates high barriers

The development of the biochip scanner sector is expected to be hampered by the high cost of the manufacturing process of biochips. The main method used to create microfluidic devices is ultraviolet lithography, which is very expensive, complicated, and calls for highly trained personnel and specific equipment.

Key Players operating in the market are constrained in their ability to enter the biochip scanner market because of the high price. Biochips scanner production is also restricted by a lack of understanding of their application in the developing market. Most microfluidic devices are developed using ultraviolet lithography, a very expensive and complex technique that requires highly specialized instruments and highly qualified staff.
Biochip Scanner Market Segment Analysis
Based on the type, the DNA chip segment is expected to contribute more than 35% share in the global biochip scanner market during the forecast period. In 2021, the market for biochip scanners was dominated by the DNA biochip scanner industry. The high costs of genomic research and next-generation sequencing, as well as the rising demand for the detection and diagnosis of genetic abnormalities, are expected to lead to an increase in the use of biochips.

The requirement for biochips and a rising number of tissue- and cell-based biochips are projected to be driven by protein microarrays. The use of DNA chips to monitor gene expression levels in cells, identify novel medications, identify differences in gene expression levels, and detect gene mutations is anticipated to drive market expansion throughout the forecast period. The market is also anticipated to expand as a result of rising global genomics spending, next-generation sequencing, and the identification and diagnosis of more genetic abnormalities.

Based on End-user, the hospitals & diagnostics center segment is expected to contribute more than 42.13% share in the global biochip scanner market. Many biotechnology companies are investing heavily in R&D initiatives to incorporate biochip technology into a range of healthcare applications. The academic & research institutes are expected to grow at a more than 6.24% rate of CAGR during the forecast period. Many institutions are conducting research and development activities on the technology and focusing on the exploration application area of the biochip scanner.
Biochip Scanner Market Regional Insights
North America region: Home to research activities for Biochip Scanner

North America held the dominant position in the global biochip scanner market. The market growth is attributed to the expanding government programs that provide tax incentives to support R&D. The developed nations like the US, and Canada have a significant concentration of biotechnology businesses, together with research and educational institutions, which has accelerated the development of biochip applications. The US and Canada are leading the market because of the abundance of university and research facilities as well as the growing use of biochip scanners in a variety of applications.

The usage of biochip scanning technology in drug development, clinical trials, toxicity studies, diagnostics, and clinical trials is growing throughout the North America region, as is the acceptance of biochip scanners in research labs. An increase in the Number of Cancer Patients is expected to drive the need for biochips. Cancer is a major public health problem across the globe and is the second leading cause of death. In the United States in 2021, more than 1,752,835 new cancer cases were reported and more than 599,580 people died of cancer. For every 100,000 people, 439 new cancer cases were reported and 146 people died of cancer.

Asia Pacific Region: The emerging opportunity for new entrance Players

The region has a high population base. The Asia Pacific biochip scanner market is expected to grow at a more than 9.18% rate of CAGR during the forecast period. The presence of a sizable patient base, better access to technology, and advancements in healthcare infrastructure, with India and China leading the pack are some of the prominent drivers, which are expected to boost the market growth. China is making significant investments in scientific research to enhance medication discovery and accelerate the development of precision medicines.

The R&D investments by pharmaceutical companies in the healthcare sector are expected to drive market growth. Thailand is home to numerous well-established tech laboratories and pharmaceutical enterprises and is prepared to embrace the current trend of sophisticated biotech development because of its advantageous location, first-rate infrastructure, and significant scientific potential. The modernization of the healthcare system in nations like Vietnam with ongoing increases in healthcare spending is expected to boost the market growth shortly.

The biochip scanner market in the Asia Pacific region is expected to drive by the factors like government funding, utilization of personalized medicine, and demand for high-speed diagnostics. Despite the many opportunities for key players operating in the market, lack of technical awareness associated with biochips, availability of alternate technologies, and low acceptance are some of the factors, which can limit the investment in the area of the biochip scanner market in Asia Pacific.
Competitive Landscape: Biochip Scanner Market
Many market key players have to take considerations regarding various federal, state, local and international laws governing the environment like the storage, use, discharge, disposal, product composition, and hazardous and toxic materials. Key players are facing complexity in their production and procurement operations because of the evolving nature of environmental compliance regulations and standards and specific customer compliance requirements. Strict regulations and standards have an impact on the material composition, which is entering in biochip scanner market.

Evolving nature of compliance with healthcare regulations and standards and end users’ compliance requirements are expected to increase the complexity for the market key players. Biochips are widely used in genomics, proteomics, customized medicine, and other applications, which prompts both established manufacturers and fresh startups to create, finance, and launch new technologies. For instance, Qurin Diagnostics is working on biochip-based cancer detection and treatment, which is built on nanotechnology and employs nanotechnology to track, identify, and treat cancer.

Biochips quickly analyze hundreds of biological processes. The chips can successfully record demographic and medical data and track individuals or animals. The multi-functionalities of the biochip scanner are expected to lead to a variety of investments among the key players. For instance, Nutcracker Company has raised the US $167m to boost its biochip-based manufacturing platform to expand its portfolio of mRNA therapies and advance its biochip-based RNA manufacturing platform technology. The company is focusing to combine the power of advanced engineering with high-precision biosynthesis to deploy an RNA therapeutics platform.

The competitive landscape of the biochip scanner market provides data on the total economic profit made by suppliers and businesses, and the sales and revenues generated in the healthcare industry. The report on the global biochip scanner market provides a summary of the business structure, the introduction of new technologies, and market opportunities for the new entrance key players. As the use of biochips for cancer treatment increases, new technologies are being introduced to the market, many key players are expected to invest in the production of the biochip scanner.
Scope of the Report
The global Biochip Scanner Market report covers the past and current status of the industry with the forecasted market size and trends. The report provides the market dynamics like drivers, restraints, opportunities, and challenges in each region. The report gives a clear representation of porter's five force analysis for the new entrance key players in the market. The report gives the market figures from 2024 to 2030 for each segment of the market with the compound annual growth rate by each region (North America, Asia Pacific, Europe, Middle East & Africa, and South America).

The investors will get a detailed analysis of the biochip scanner with the countrywide information (US, Canada, Mexico, UK, Italy, Germany, France, rest of Europe, China, India, Japan, South Korea, Thailand, Malaysia, rest of APAC, ASEAN, South Africa, GCC countries, rest of MEA, Brazil, Argentina, and rest of South America). The data have been collected in the report from primary and secondary sources. The market figures have been calculated and estimated based on the annual reports of the key players operating in the market, investment by key players, Government funding, and healthcare data figures.
Biochip Scanner Market Scope: Inquire before buying



Biochip Scanner Market


Report Coverage
Details


Base Year:
2023
Forecast Period:
2024-2030


Historical Data:
2018 to 2023
Market Size in 2023:
US $ 12.79 Bn.


Forecast Period 2024 to 2030 CAGR:
11.47%
Market Size in 2030:
US $ 27.36 Bn.


 Segments Covered:
by Type
1. DNA Chips
2. Lab-On-A-Chip
3. Protein Chips
4. Cancer Diagnosis and Treatment
5. Gene Expression
6. Single Nucleotide Polymorphism (SNP) Genotyping
7. Genomics
8. Drug Discovery
9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening)


by End-User
1. Biotechnology & Pharmaceutical Companies
2. Hospitals & Diagnostics Centers
3. Academic & Research Institutes



Biochip Scanner Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Biochip Scanner Market, Key Players are
1. Agilent Technologies, Inc
2. Bio-Rad Laboratories, Inc
3. Cepheid Inc
4. Fluidigm Corporation
5. GE Healthcare
6. Hoffman-La-Roche Ltd
7. Illumina, Inc
8. Ocimum Biosolutions Ltd
9. PerkinElmer, Inc
10. Takara Bio Inc
11. Thermo Fisher Scientific Inc
12. Merck Millipore
13. Sigma-Aldrich Corporation
14. Abbott Laboratories
15. bioMerieux SA
16. F. Hoffmann-La Roche Ltd
17. HORIBA, Ltd.
18. PerkinElmer, Inc.
19. Randox Laboratories Ltd

Frequently Asked Questions:

1] What segments are covered in the Global Biochip Scanner Market report?
Ans. The segments covered in the Global Biochip Scanner Market report are based on Type and End-Users.

2] Which region is expected to hold the highest share in the Global Biochip Scanner Market?
Ans. The North America region is expected to hold the highest share in the Global Biochip Scanner Market.

3] What is the market size of the Global Biochip Scanner Market by 2030?
Ans. The market size of the Global Biochip Scanner Market by 2030 is expected to reach USD 27.36 Bn.

4] What is the forecast period for the Global Biochip Scanner Market?
Ans. The forecast period for the Global Biochip Scanner Market is 2024-2030

5] What was the market size of the Global Biochip Scanner Market in 2023?
Ans. The market size of the Global Biochip Scanner Market in 2023 was valued at USD 12.79 Bn.